Adcock Ingram is a South African pharmaceutical company. The company occupies a 10% share of the private pharmaceutical industry in South Africa. Adcock Ingram provides an extensive range of branded and generic prescription and OTC products in a broad range of therapeutic classes. In generics, the Company markets a broad range of affordable products under the corporate brand. In branded products, the Company markets many well-recognised leading brands. Adcock Ingram Critical Care is South Africa's largest supplier of hospital and critical-care products, blood systems and accessories as well as products used for renal dialysis and transplant medication. Adcock Ingram has a joint venture with Synexus Clinical Research plc called AddClin Research, a Phase I clinical research facility. AddClin Research offers a one-stop clinical research service extending from study design development through to writing protocols, obtaining necessary regulatory approvals, clinical execution, reports and post-marketing surveillance.